June 25th 2025
Marketed as Orlynvah, oral sulopenem from Iterum Therapeutics was FDA approved last fall for uncomplicated urinary tract infections (uUTIs), and has shown efficacy against infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
CDC, FDA Investigating Eye Drops Linked to Bacterial Infection
April 3rd 2023According to the CDC, the outbreak strain of carbapenem-resistant Pseudomonas aeruginosa with Verona integron-mediated metallo-β-lactamase and Guiana extended-spectrum-β-lactamase (VIM-GES-CRPA), has never been reported in the US prior to this outbreak.
Read More
So You Made the Decision to Implement Vancomycin AUC Dosing. Now What?
Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.
Read More
Linezolid Coadministration With Medications for Opioid Use Disorder: A Serotonin Toxicity Tightrope?
February 16th 2023This study characterized the incidence of serotonin syndrome and identified contributing risk factors with combined medications for opioid use disorder (MOUD) and linezolid use.
Read More
Inappropriate Prescribing of Antibiotics Associated with Increased Costs, Adverse Events
February 13th 2023Six respiratory infections are among the most common diagnoses for which antibiotics often are inappropriately prescribed, and new research sheds light on the effects, both in increased risk of adverse events and excess health care costs.
Read More